UK-CAB 9 – Vaccines and microbicides
21 May 2004
Report from the 9th Meeting as a word file [1MB]
Venue Details
PowerPoint presentations from the meeting
Provisional agenda for the meeting
PowerPoint Slides from the meeting
Henry Graeme-Smith
Intorduction to basic vaccine technology [416k]
Jo Robinson
Topical microbicides [3.4MB]
Maite Suarez
Internationl AIDS Vaccine Initiative (IAVI) [1.8MB]
Julian Meldrum
Community involvement in vaccine and microbicide research and CAB proposals [48k]
Saul Walker
Thorn issues in HIV vaccines [272k]
Link to top of page
Provisional agenda for the meeting
| 08:45–09:00 | Registration and coffee/tea |
| 09:00 | Introduction and welcome to the 9th UK-CAB |
The subjects we will cover for training will include:
|
|
| 13:00–14:00 | Lunch |
| 14:00–16:00 | Company meeting: Tibotec |
| 16:00–16:30 | AOB, etc |
| 16:30 | Meeting close |
At this meeting the CAB will be 2 years old – thanks to everyone for making it such a good project to be involved with. It is probably a good time to evaluate the format of the meetings and group again.
Financial support
The UK-CAB receives unrestricted funding from some pharmaceutical companies towards the direct costs of holding four meetings each year. This funding supports the travel and accommodation costs for members to attend from outside London, plus the cost of catering.
The content, programme and agenda for meetings is decided by the UK-CAB steering group in consultation with the wider membership. Funding is unconnected to meeting content.
We believe that manufacturers who currently develop and market medicines have a responsibility to actively engage with advocacy organisations and that HIV positive people and their advocates should be able to directly question manufacturers about the safety and efficacy of their products and proposals for future research.
For a list of companies that support the UK-CAB please see the “about us” page.
Link to top of page